Clinical Trial Update: TH1902 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for TH1902 in patients with advanced solid tumors. The study is currently active/not recruiting and includes multiple in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Endometrial Cancer
• Epithelial Ovarian Cancer
• Hormone Receptor-positive Breast Cancer
• Prostate Cancer
• Small Cell Lung Cancer
• Thyroid Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• TH1902

Snippet

Sponsor: Theratechnologies | Conditions: Solid Tumor, TNBC - Triple-Negative Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING